Orphenadrine Citrate Tablet, Extended Release
Product Images NDC 72162-2020

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 72162-2020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Ccdf0ccb 14f9 46c3 Bc8c 84a8b0cb48c8 01)

Image (Ccdf0ccb 14f9 46c3 Bc8c 84a8b0cb48c8 01)
Chemical structure diagram of orphenadrine citrate, showing the molecular composition and bonds of the active ingredient orphenadrine citrate used in the extended-release tablets.*
FDA Label Image

Label (Lbl721622020)

Label (Lbl721622020)
Label for Orphenadrine Citrate Extended-Release Tablets, 100 mg, containing 100 tablets. The label includes NDC 72162-2020-1 and is marked for prescription use only. It shows the product is relabeled by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by Novel Laboratories, Inc. Storage and safety instructions are also included, with a barcode on the right.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.